Fmoc-L-beta-HAsp(tBu)-OH

Fmoc-L-beta-HAsp(tBu)-OH is an Fmoc-protected β-linked aspartic acid derivative featuring a free carboxylic acid and a tert-butyl-protected side-chain carboxyl group, preserving the L-configuration at the β-amino acid stereocenter. The structure combines an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group with a tBu ester on the side-chain, creating a controlled, orthogonally protected amino acid building block for peptide assembly. The β-amino acid framework and the protected side-chain carboxyl enable selective peptide coupling at the α-amino position while deferring side-chain functionalization until deprotection. The presence of a stable Fmoc carbamate and a acid-labile tBu ester defines a predictable reactivity profile for stepwise synthesis, downstream derivatization, and conversion into functionalized aspartate-containing motifs.

1. Peptide Synthesis

Fmoc-L-beta-HAsp(tBu)-OH is applied in solid-phase and solution-phase peptide synthesis where β-amino acid incorporation is required to construct aspartate-containing sequences with altered backbone geometry. The Fmoc carbamate protects the α-amino group during coupling cycles, while the tBu ester masks the side-chain carboxyl to prevent competing acylation or side reactions. The β-amino acid connectivity can be used to introduce conformational constraints and to generate peptide analogs that maintain controlled functional group placement for subsequent deprotection and coupling. Stepwise removal of the Fmoc group and later side-chain deprotection supports sequential assembly and the preparation of β-aspartate peptide building blocks for research-grade peptide libraries and process-compatible syntheses.

2. Side-Chain Functionalization

Fmoc-L-beta-HAsp(tBu)-OH serves as a protected amino acid intermediate for side-chain carboxyl derivatization workflows in chemical synthesis and biochemical reagent preparation. The masked side-chain carboxyl as a tBu ester allows planned activation after orthogonal deprotection, enabling formation of amides, esters, or activated carboxyl derivatives for downstream conjugation chemistry. The β-amino acid scaffold provides a spatially defined handle for introducing linkers, charged groups, or bioorthogonal motifs while maintaining compatibility with peptide-like frameworks. Resulting derivatives can function as intermediates for peptidomimetic construction, affinity probes, or labeled aspartate-containing molecules where controlled exposure of the side-chain functionality is required.

3. Peptidomimetics And SAR Studies

Fmoc-L-beta-HAsp(tBu)-OH is used in peptidomimetic and structure-activity relationship studies to generate β-aspartate analogs that probe how backbone modification influences molecular recognition. The combination of an Fmoc-protected amino terminus and a protected side-chain carboxyl enables systematic variation of peptide length, side-chain substitution patterns, and terminal functional groups without premature cross-reactivity. The stereodefined L-configuration supports consistent chiral presentation in synthesized analogs, which is relevant for comparing structure-function relationships across related scaffolds. Synthesized β-aspartate-containing peptides and analogs can then be used as chemical probes or comparative reagents in SAR workflows and molecular design programs focused on backbone engineering.

4. Protein Engineering

Fmoc-L-beta-HAsp(tBu)-OH can be employed in protein engineering and protein modification research where β-amino acid residues are introduced to modulate local structure, stability, or interaction surfaces. The protected α-amino group and masked side-chain carboxyl support incorporation into peptide segments that can be used as building blocks for larger constructs, including engineered domains and constrained peptide linkers. The orthogonal protecting-group strategy aligns with iterative assembly of functional segments, enabling later unveiling of the side-chain carboxyl for attachment of additional moieties or crosslinking partners. Downstream products derived from this chiral β-amino acid intermediate can serve as defined inputs for studying backbone-dependent behavior in engineered biomolecular systems.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-beta-HAsp(tBu)-OH is relevant to pharmaceutical manufacturing and fine chemical synthesis as a protected amino acid intermediate for producing peptide-based intermediates and structurally defined building blocks. The Fmoc/tBu protection scheme supports controlled processing steps where N-protection enables repeated coupling operations, while side-chain masking limits undesired side reactions during scale-up chemistry. The presence of a free carboxylic acid at the α-position provides a functional site that can be carried through manufacturing sequences and later transformed into activated derivatives as required for further assembly. Resulting β-aspartate-containing intermediates can be integrated into downstream synthetic routes for peptide analog production, process development, and manufacturing of research-grade or development-stage materials requiring robust protection/deprotection logic.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. The spatiotemporal control of signalling and trafficking of the GLP-1R